Skip to main content
OpenTrials
Completed

NCT Number: NCT01307904

The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study.

The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Internal Medicine Department, FMHS, UAE University

Al Ain City, Abu Dhabi Emirate, United Arab Emirates

About this study

The United Arab Emirates (UAE) has transitioned rapidly over the last 40 years. This has lead to a dramatic increase in the prevalence of obesity, metabolic syndrome, dyslipidaemia, hypertension, prediabetes and diabetes. Daily consumption of dates is the norm.The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested equally in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study. The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items with potential health benefits for healthy and diabetic individuals alike.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult
  • Healthy or having controlled type 2 diabetes mellitus

Exclusion criteria

  • Morbid obesity (BMI > 40)
  • Presence of gastroenterological disorders
  • Alimentary tract surgery
  • A history of gastroenteritis in the prior six months
  • Any disease that may affect glucose metabolism
  • Alcohol intake
  • Smoking
  • Taking any medications (except metformin)
  • Poorly uncontrolled diabetes (HbA1c > 8%)
  • The presence of chronic diseases or the presence of acute illness

Treatment and study plan

Glucose

Other

Each healthy and Diabetic volunteers received 50 grams of glucose

Dates

Other

Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days.

Primary outcomes

  1. Dates Glycemic Index

    Time frame: 4 months

    Measuring the composition of dates, selection of patients and carrying out the study

Sponsors and collaborators

Lead sponsor

United Arab Emirates University

Other

Collaborators

  • Abu Dhabi Food Control Authority

Registry information

Acronym: Dates

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Mar 3, 2011
Registry last updated
Mar 3, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.